Sale disclosed
Nelson Sun
See Remarks
Common Stock, par value $0.00001 per share
- Reported value
- $73.78K
- Reported price
- $5.0006 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Aardvark Therapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $394.96K by 1 insider.
See Remarks
Common Stock, par value $0.00001 per share
See Remarks
Common Stock, par value $0.00001 per share
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| See Remarks | Common Stock, par value $0.00001 per shareSale10b5-1 | 14,754$5.00 / share | $73.78K | Sep 10Filed Sep 11 · 1d later | SEC filing |
| See Remarks | Common Stock, par value $0.00001 per shareSale10b5-1 | 62,000$5.18 / share | $321.18K | Sep 11Filed Sep 11 · 0d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.